Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-04-10 4:50 pm Purchase | 2024-03-24 | 13D | Landos Biopharma, Inc. LABP | Xontogeny LLC | 309,092 9.900% | 309,092 (New Position) | Filing History |
| 2023-03-30 5:27 pm Unchanged | 2023-03-23 | 13D | Landos Biopharma, Inc. LABP | Xontogeny LLC | 309,092 9.900% | 0 (Unchanged) | Filing History |
| 2022-08-09 09:19 am Purchase | 2022-08-09 | 13D | Landos Biopharma, Inc. LABP | Xontogeny LLC | 309,092 7.700% | 309,092 (New Position) | Filing History |
| 2021-06-25 5:01 pm Purchase | 2021-06-08 | 13D | Astria Therapeutics, Inc. ATXS | Xontogeny LLC | 1,281,198 9.900% | 1,281,198 (New Position) | Filing History |